Updated Technicals of Fulgent Genetics (NASDAQ: FLGT): 28 July 2020

Updated Technicals of Fulgent Genetics (NASDAQ: FLGT):

28 July 2020
(Click on the Technical Chart Above to Expand)

Attached is the Updated Technicals of Fulgent Genetics (NASDAQ: FLGT). Fulgent has just completed its significant re-accumulation. It is a stock that will outperform regardless of the broad index markets' performances, i.e. it goes up disregarding if broad markets are in bull or bear market. It is one of the good hedges together with Gold. The holy trinity of further re-accumulation is as illustrated. These are show of intentions. The green circled region of breakout is further declaration of market intention to mark up prices. If you had bought with me at $4.79 (refer to past analyses), your returns has furthered bloated from +350% to +552% now. You can continue to expect your returns to be at least +1000%. Target prices are $31.50 and $63.00 respectively.

The Donovan Norfolk Technical Rating:
Bullish

All Past Fulgent Genetics Analyses:
https://donovan-ang.blogspot.com/search/label/Fulgent%20Genetics

DISCLAIMER

This analysis site, as well as the analyses in it, is created for the sole purpose of education, discussion, fundamental analysis knowledge sharing, technical analysis knowledge sharing, funds flow analysis knowledge sharing, general skills-knowledge sharing and opinions sharing. The contents of this blog are not to be taken as investment advice or inducement to trade, and I take no responsibility for any gains or losses as a result of reading my analyses, judgements and opinions. In essence, practise due diligence. 

Updated Technicals of Fulgent Genetics (NASDAQ: FLGT): 13 February 2020

Updated Technicals of Fulgent Genetics (NASDAQ: FLGT):

13 February 2020
(Click on the Technical Chart Above to Expand)

Attached is the Updated Technicals of Fulgent Genetics (NASDAQ: FLGT). Fulgent is on a powerful uptrend channel as shown. It is repeating the break-ups of pink resistances while at yellow trendline supports (refer to all 3 circled regions in dark green). It has broken up light green resistances and is now making it the support. Price Actions with respect to Linear Regression is bullish, of buying mode, and aggressive. The breakup of light green resistance was done using cup and handle re-accumulation. Consistent re-accumulation within the yellow channel is persistent and relentless. If you had bought with me at $4.79 , your returns is now +350% now. You can expect your returns to be +1000%, i.e. another more than 200% returns from current point.

The Donovan Norfolk Technical Rating:
Bullish

All Past Fulgent Genetics Analyses:
https://donovan-ang.blogspot.com/search/label/Fulgent%20Genetics

DISCLAIMER

This analysis site, as well as the analyses in it, is created for the sole purpose of education, discussion, fundamental analysis knowledge sharing, technical analysis knowledge sharing, funds flow analysis knowledge sharing, general skills-knowledge sharing and opinions sharing. The contents of this blog are not to be taken as investment advice or inducement to trade, and I take no responsibility for any gains or losses as a result of reading my analyses, judgements and opinions. In essence, practise due diligence. 

Technicals of Fulgent Genetics (NASDAQ: FLGT): 29 January 2020

Technicals of Fulgent Genetics (NASDAQ: FLGT):

29 January 2020
(Click on the Technical Chart Above to Expand)

Attached is the Technicals of Fulgent Genetics (NASDAQ: FLGT).
Trinity of Special Forces with purposeful consolidation.

The Donovan Norfolk Technical Rating:
Bullish

DISCLAIMER

This analysis site, as well as the analyses in it, is created for the sole purpose of education, discussion, fundamental analysis knowledge sharing, technical analysis knowledge sharing, funds flow analysis knowledge sharing, general skills-knowledge sharing and opinions sharing. The contents of this blog are not to be taken as investment advice or inducement to trade, and I take no responsibility for any gains or losses as a result of reading my analyses, judgements and opinions. In essence, practise due diligence. 

Fulgent Genetics Inc (NASDAQ: FLGT): 1 March 2018, Thursday, 12.02pm Singapore Time

Fulgent Genetics Inc (NASDAQ: FLGT): 

1 March 2018, Thursday, 12.02pm Singapore Time

(Click on Technical Chart Above to Expand)

Attached is the Technicals for Fulgent Genetics Inc, a company that is listed in NASDAQ (NASDAQ: FLGT). There were 2 high volume buys in November of 2017. This stock was then supported successfully in December of 2017 and February of 2018. It is worth noting that the high fear correction that happened worldwide in February of 2018 had no effect on Fulgent Genetics Inc, a sign of great strength. The successful supports in green serve as confirmation for previous large buy volumes in November of 2017. First target for Fulgent Genetics Inc is $10.00.

Donovan Norfolk Ang

Valeant Pharmaceuticals (NYSE: VRX): 1 March 2018, Thursday, 11.36am Singapore Time

Valeant Pharmaceuticals (NYSE: VRX): 

1 March 2018, Thursday, 11.36am Singapore Time

(Click on Technical Chart Above to Expand)

Today I received some enquiries about Valeant Pharmaceuticals (NYSE: VRX) -- The Donovan Norfolk Technical Buy Rating given to it on 18 May 2017 to scoop the bottom of Valeant @ $13.25. As I am now uncomfortable with the debt levels of Valeant Pharmaceuticals, and I judge that it is the debt levels of this company that is preventing it from further rally (as can be seen from selling volumes starting to take over again), I will abolish this speculative buy now and exit with whatever profits that is on hand. This speculation cannot be held for longer term because selling is coming back and the debt levels of Valeant is making me uncomfortable. For those who still want to stay within the healthcare sector, this is what I will do: I will now use the capital plus profits made from this trade and transit it to Fulgent Genetics Inc (NASDAQ: FLGT), in order to stay relevant within the healthcare industry for the same batch of bullets plus profits made from Valeant Pharmaceuticals. 

Reference (Previous Scoop-The-Bottom Analysis on Valeant Pharmaceuticals):
http://donovan-ang.blogspot.sg/2017/05/valeant-pharmaceuticals-nyse-vrx-18-may.html

Donovan Norfolk Ang